These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 16040180

  • 1. Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.
    Takano A, Suhara T, Kusumi I, Takahashi Y, Asai Y, Yasuno F, Ichimiya T, Inoue M, Sudo Y, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):75-81. PubMed ID: 16040180
    [Abstract] [Full Text] [Related]

  • 2. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.
    Takano A, Suhara T, Ikoma Y, Yasuno F, Maeda J, Ichimiya T, Sudo Y, Inoue M, Okubo Y.
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):19-26. PubMed ID: 14764214
    [Abstract] [Full Text] [Related]

  • 3. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.
    Arakawa R, Ito H, Takano A, Takahashi H, Morimoto T, Sassa T, Ohta K, Kato M, Okubo Y, Suhara T.
    Psychopharmacology (Berl); 2008 Apr; 197(2):229-35. PubMed ID: 18058087
    [Abstract] [Full Text] [Related]

  • 4. Extrastriatal dopamine D(2) receptor occupancy in olanzapine-treated patients with schizophrenia.
    Arakawa R, Ito H, Okumura M, Takano A, Takahashi H, Takano H, Okubo Y, Suhara T.
    Eur Arch Psychiatry Clin Neurosci; 2010 Jun; 260(4):345-50. PubMed ID: 19851803
    [Abstract] [Full Text] [Related]

  • 5. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [Abstract] [Full Text] [Related]

  • 6. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.
    J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
    [Abstract] [Full Text] [Related]

  • 7. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [Abstract] [Full Text] [Related]

  • 8. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P, Tallerico T.
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [Abstract] [Full Text] [Related]

  • 9. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 10. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P, Tallerico T.
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [Abstract] [Full Text] [Related]

  • 11. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [Abstract] [Full Text] [Related]

  • 12. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A, Arakawa R, Okumura M, Fukuta H, Honjo K, Ishihara K, Nakamura H, Kumita S, Okubo Y.
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [Abstract] [Full Text] [Related]

  • 13. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
    Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C.
    Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.
    Arakawa R, Ito H, Takano A, Okumura M, Takahashi H, Takano H, Okubo Y, Suhara T.
    Psychopharmacology (Berl); 2010 May; 209(4):285-90. PubMed ID: 20349050
    [Abstract] [Full Text] [Related]

  • 15. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G.
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [Abstract] [Full Text] [Related]

  • 16. A new framework for investigating antipsychotic action in humans: lessons from PET imaging.
    Kapur S.
    Mol Psychiatry; 1998 Mar; 3(2):135-40. PubMed ID: 9577837
    [Abstract] [Full Text] [Related]

  • 17. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
    Olsen CK, Brennum LT, Kreilgaard M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):318-27. PubMed ID: 18325493
    [Abstract] [Full Text] [Related]

  • 18. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep 28; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.
    Int J Neuropsychopharmacol; 2010 Aug 28; 13(7):951-60. PubMed ID: 20392299
    [Abstract] [Full Text] [Related]

  • 20. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.
    Ikoma Y, Ito H, Arakawa R, Okumura M, Seki C, Shidahara M, Takahashi H, Kimura Y, Kanno I, Suhara T.
    Neuroimage; 2008 Oct 01; 42(4):1285-94. PubMed ID: 18585466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.